Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 93

1.

Sequence motifs associated with hepatotoxicity of locked nucleic acid--modified antisense oligonucleotides.

Burdick AD, Sciabola S, Mantena SR, Hollingshead BD, Stanton R, Warneke JA, Zeng M, Martsen E, Medvedev A, Makarov SS, Reed LA, Davis JW 2nd, Whiteley LO.

Nucleic Acids Res. 2014 Apr;42(8):4882-91. doi: 10.1093/nar/gku142. Epub 2014 Feb 18.

2.

Comparison of hepatic transcription profiles of locked ribonucleic acid antisense oligonucleotides: evidence of distinct pathways contributing to non-target mediated toxicity in mice.

Kakiuchi-Kiyota S, Koza-Taylor PH, Mantena SR, Nelms LF, Enayetallah AE, Hollingshead BD, Burdick AD, Reed LA, Warneke JA, Whiteley LO, Ryan AM, Mathialagan N.

Toxicol Sci. 2014 Mar;138(1):234-48. doi: 10.1093/toxsci/kft278. Epub 2013 Dec 11.

3.

Cerebral venous infarction: a potentially avoidable complication of deep brain stimulation surgery.

Morishita T, Okun MS, Burdick A, Jacobson CE 4th, Foote KD.

Neuromodulation. 2013 Sep-Oct;16(5):407-13; discussion 413. doi: 10.1111/ner.12052. Epub 2013 Jun 5.

4.

High-throughput gene silencing and mRNA expression analysis in hepatocyte sandwich cultures.

Hollingshead BD, Gauthier LM, Burdick AD.

Curr Protoc Toxicol. 2013 Feb;Chapter 14:Unit 14.11. doi: 10.1002/0471140856.tx1411s55.

PMID:
23408193
5.

Safe, long-term hepatic expression of anti-HCV shRNA in a nonhuman primate model.

Suhy DA, Kao SC, Mao T, Whiteley L, Denise H, Souberbielle B, Burdick AD, Hayes K, Wright JF, Lavender H, Roelvink P, Kolykhalov A, Brady K, Moschos SA, Hauck B, Zelenaia O, Zhou S, Scribner C, High KA, Renison SH, Corbau R.

Mol Ther. 2012 Sep;20(9):1737-49. doi: 10.1038/mt.2012.119. Epub 2012 Jun 26.

6.

The teledermatology train is coming: get on board, get out of the way, or get run over.

Burdick AE, Simmons SC.

Cutis. 2011 Nov;88(5):213-4. No abstract available.

PMID:
22272479
7.

Telehealth practice recommendations for diabetic retinopathy, second edition.

Li HK, Horton M, Bursell SE, Cavallerano J, Zimmer-Galler I, Tennant M, Abramoff M, Chaum E, Debuc DC, Leonard-Martin T, Winchester M; American Telemedicine Association Diabetic Retinopathy Telehealth Practice Recommendations Working Group, Lawrence MG, Bauman W, Gardner WK, Hildebran L, Federman J.

Telemed J E Health. 2011 Dec;17(10):814-37. doi: 10.1089/tmj.2011.0075. Epub 2011 Oct 4. Review.

PMID:
21970573
8.

Chronic rhinitis: a manifestation of leprosy.

Camacho ID, Burdick A, Benjamin L, Casiano R.

Ear Nose Throat J. 2011 Sep;90(9):E1-3.

PMID:
21938685
9.

Evidence-based practice for telemental health.

Grady B, Myers KM, Nelson EL, Belz N, Bennett L, Carnahan L, Decker VB, Holden D, Perry G, Rosenthal L, Rowe N, Spaulding R, Turvey CL, White R, Voyles D; American Telemedicine Association Telemental Health Standards and Guidelines Working Group.

Telemed J E Health. 2011 Mar;17(2):131-48. doi: 10.1089/tmj.2010.0158. No abstract available.

PMID:
21385026
10.

Advancing deep brain stimulation for obsessive-compulsive disorder.

Burdick AP, Foote KD.

Expert Rev Neurother. 2011 Mar;11(3):341-4. doi: 10.1586/ern.11.20.

PMID:
21375439
11.

A potential role for complement in immune evasion by Mycobacterium leprae.

Callegaro-Filho D, Shrestha N, Burdick AE, Haslett PA.

J Drugs Dermatol. 2010 Nov;9(11):1373-82.

PMID:
21061760
12.

Do patient's get angrier following STN, GPi, and thalamic deep brain stimulation.

Burdick AP, Foote KD, Wu S, Bowers D, Zeilman P, Jacobson CE, Ward HE, Okun MS.

Neuroimage. 2011 Jan;54 Suppl 1:S227-32. doi: 10.1016/j.neuroimage.2010.09.077. Epub 2010 Oct 4.

13.

Prevalence of Twiddler's syndrome as a cause of deep brain stimulation hardware failure.

Burdick AP, Okun MS, Haq IU, Ward HE, Bova F, Jacobson CE, Bowers D, Zeilman P, Foote KD.

Stereotact Funct Neurosurg. 2010;88(6):353-9. doi: 10.1159/000319039. Epub 2010 Sep 22.

PMID:
20861658
14.

Relationship between higher rates of adverse events in deep brain stimulation using standardized prospective recording and patient outcomes.

Burdick AP, Fernandez HH, Okun MS, Chi YY, Jacobson C, Foote KD.

Neurosurg Focus. 2010 Aug;29(2):E4. doi: 10.3171/2010.4.FOCUS10100.

PMID:
20672921
15.

Lack of benefit of accumbens/capsular deep brain stimulation in a patient with both tics and obsessive-compulsive disorder.

Burdick A, Foote KD, Goodman W, Ward HE, Ricciuti N, Murphy T, Haq I, Okun MS.

Neurocase. 2010 Aug;16(4):321-30. doi: 10.1080/13554790903560422. Epub 2010 Feb 22.

PMID:
20178034
16.

Oral health status of New Hampshire Head Start children, 2007-2008.

Anderson L, Martin NR, Burdick A, Flynn RT, Blaney DD.

J Public Health Dent. 2010 Summer;70(3):245-8. doi: 10.1111/j.1752-7325.2009.00161.x.

PMID:
20149064
17.

Integrated pathways for neutrophil recruitment and inflammation in leprosy.

Lee DJ, Li H, Ochoa MT, Tanaka M, Carbone RJ, Damoiseaux R, Burdick A, Sarno EN, Rea TH, Modlin RL.

J Infect Dis. 2010 Feb 15;201(4):558-69. doi: 10.1086/650318.

18.

Economic evaluation of telemedicine: review of the literature and research guidelines for benefit-cost analysis.

Dávalos ME, French MT, Burdick AE, Simmons SC.

Telemed J E Health. 2009 Dec;15(10):933-48. doi: 10.1089/tmj.2009.0067.

PMID:
19954346
19.

Identification and management of deep brain stimulation intra- and postoperative urgencies and emergencies.

Morishita T, Foote KD, Burdick AP, Katayama Y, Yamamoto T, Frucht SJ, Okun MS.

Parkinsonism Relat Disord. 2010 Mar;16(3):153-62. doi: 10.1016/j.parkreldis.2009.10.003. Epub 2009 Nov 5. Review.

20.

Divergence of macrophage phagocytic and antimicrobial programs in leprosy.

Montoya D, Cruz D, Teles RM, Lee DJ, Ochoa MT, Krutzik SR, Chun R, Schenk M, Zhang X, Ferguson BG, Burdick AE, Sarno EN, Rea TH, Hewison M, Adams JS, Cheng G, Modlin RL.

Cell Host Microbe. 2009 Oct 22;6(4):343-53. doi: 10.1016/j.chom.2009.09.002.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk